Lipid-Derived Biomarkers for NAION

Overview

A recent study investigates the potential of lipid-derived indices, specifically the atherogenic index of plasma (AIP) and triglyceride–glucose (TyG) index, as biomarkers for nonarteritic anterior ischemic optic neuropathy (NAION). The findings suggest these indices may reflect systemic metabolic vulnerability associated with NAION, even in patients without overt hyperlipidemia.

Background

Nonarteritic anterior ischemic optic neuropathy (NAION) is a significant condition in ophthalmology, characterized by sudden vision loss due to ischemia of the optic nerve. Despite the recognition of systemic vascular risk factors, there are currently no established biomarkers to aid in diagnosis or risk stratification. Understanding the metabolic underpinnings of NAION could enhance clinical management and patient outcomes.

Data Highlights

Key Findings

• Both AIP and TyG indices were significantly elevated in NAION patients compared to controls.
• Traditional lipid parameters were largely within normal limits in both groups.
• Neither AIP nor TyG correlated with functional or structural severity measures in NAION.
• Elevated AIP indicates a more atherogenic lipid profile, while TyG serves as a surrogate marker of insulin resistance.
• The study suggests that NAION may represent a systemic metabolic disease rather than solely a local optic nerve event.

Clinical Implications

The findings indicate that lipid-derived indices may provide insights into the systemic metabolic status of NAION patients, particularly those without overt dyslipidemia. While these markers are not yet ready to influence clinical management, they highlight the need for expanded metabolic profiling in unexplained NAION cases.

Conclusion

This study contributes to the understanding of NAION as potentially linked to systemic metabolic factors, suggesting that lipid metabolism may play a more significant role in optic nerve ischemia than previously recognized.

References

1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Additional Predictive Value of Blood-Based Liver Fibrosis Indicators in Assessing Cardiovascular Risk
2. Retinal Physician, 2020 -- Non-CNV Predictors of Success of Anti-VEGF for AMD
3. Journal of Gastroenterology, 2017 -- Approaches for Diagnosing and Monitoring Nonalcoholic Fatty Liver Disease Using Invasive and Noninvasive Techniques
4. Retinal Physician, 2010 -- Nonarteritic Anterior Ischemic Optic Neuropathy Recommendations
5. Evaluation and management of nonarteritic anterior ischemic optic neuropathy: a national survey - PMC, 2024
6. Optic Nerve Decompression Surgery for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Is Not Effective and May Be Harmful | JAMA | JAMA Network
7. Potential Value of Novel Lipid-Derived Indicator as a Biomarker for Nonarteritic Anterior Ischemic Optic Neuropathy - PMC
8. Evaluation and management of nonarteritic anterior ischemic optic neuropathy: a national survey - PMC
9. Optic Nerve Decompression Surgery for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Is Not Effective and May Be Harmful | JAMA | JAMA Network
10. Potential Value of Novel Lipid-Derived Indicator as a Biomarker for Nonarteritic Anterior Ischemic Optic Neuropathy - PMC